Quantitative proteome and lysine succinylome analyses provide insights into metabolic regulation in breast cancer

Breast Cancer : the Journal of the Japanese Breast Cancer Society
Chenchen LiuBo Zhang

Abstract

Breast cancer, the most common invasive cancer and cause of cancer-related death in women worldwide, is a multifactorial, complex disease, and many molecular players and mechanisms underlying the complexity of its clinical behavior remain unknown. To explore the molecular features of breast cancer, quantitative proteome and succinylome analyses in breast cancer were extensively studied using quantitative proteomics techniques, anti-succinyl lysine antibody-based affinity enrichment, and high-resolution LC-MS/MS analysis. Our study is the first to detect the regulation of lysine succinylation in breast cancer progression. We identified a novel mechanism by which the pentose phosphate pathway and the endoplasmic reticulum protein processing pathway might be regulated via lysine succinylation in their core enzymes. These results expand our understanding of tumorigenesis mechanisms and provide a basis for further characterization of the pathophysiological roles in breast cancer progression, laying a foundation for innovative and novel breast cancer drugs and therapies.

References

Jan 1, 1985·Annals of the New York Academy of Sciences·R A QuinlanW W Franke
Jun 5, 1998·The International Journal of Biochemistry & Cell Biology·G SchenkP F Nixon
Feb 10, 2007·The FEBS Journal·Hiderou Yoshida
Apr 17, 2007·Experimental Cell Research·Thomas M MaginRudolf E Leube
May 8, 2008·Histochemistry and Cell Biology·Roland MollLutz Langbein
Apr 1, 2009·Journal of Experimental & Clinical Cancer Research : CR·Hui ChenSong Zhang
Apr 29, 2009·The Journal of Biological Chemistry·Emer KellyShane J O'Neill
Oct 21, 2009·The Journal of Cell Biology·Preethi VijayarajThomas M Magin
Jan 30, 2010·FEBS Letters·Anne-Marie FortierMonique Cadrin
Feb 16, 2010·The Lancet Oncology·Rinat YerushalmiKaren A Gelmon
Dec 15, 2010·Nature Chemical Biology·Zhihong ZhangYingming Zhao
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Aug 18, 2012·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Sudhakaran PrabakaranJeremy Gunawardena
Feb 26, 2013·Journal of Clinical Pathology·Nirmala Pathmanathan, Rosemary L Balleine
Jul 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Kooshyar Mohammad MahdiKhadijeh Nasiri
Oct 15, 2013·Cancer Discovery·Matthew J EllisUNKNOWN Clinical Proteomic Tumor Analysis Consortium (CPTAC)
Jul 13, 2014·Protein & Cell·Peng JiangMian Wu
Jul 22, 2014·Nature·Bing ZhangUNKNOWN NCI CPTAC
Jul 24, 2014·Nature Reviews. Molecular Cell Biology·Chunaram ChoudharyMatthias Mann
Apr 16, 2015·Journal of Proteome Research·Nathan J EdwardsKaren A Ketchum
Jul 9, 2016·Oncotarget·Santiago Diaz-MoralliMarta Cascante
Aug 10, 2016·Pathology Oncology Research : POR·Akira ShimizuOsamu Ishikawa
Sep 16, 2016·Nature·Ruedi Aebersold, Matthias Mann
May 28, 2017·International Journal of Clinical Oncology·Yosuke MiuraMasanobu Yamada

❮ Previous
Next ❯

Citations

Jun 3, 2021·International Journal of Molecular Sciences·Emanuela Di GregorioGiuseppe Corona
Sep 5, 2019·Journal of Proteome Research·Yan GaoSangkyu Lee
Aug 20, 2021·Cancer Management and Research·Sisi HuangLiang Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.